Low left ventricular ejection fraction, complication rescue, and long-term survival after coronary artery bypass

Shuab Omer1, Ademola Adeseye1, Ernesto Jimenez2

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.

Insights

Low left ventricular ejection fraction (LVEF) increases complications after coronary artery bypass grafting (CABG). However, patients rescued from complications face worse long-term survival, irrespective of LVEF.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Outcomes Research

Background:

  • Low left ventricular ejection fraction (LVEF) is a known risk factor for adverse outcomes following cardiac surgery.
  • The impact of LVEF on long-term survival after isolated coronary artery bypass grafting (CABG), particularly in the context of perioperative complications, requires further elucidation.

Purpose of the Study:

  • To evaluate the association between reduced LVEF, the occurrence of perioperative complications, and long-term survival after isolated CABG.
  • To investigate whether complication rescue modifies the relationship between LVEF and long-term mortality.

Main Methods:

  • A national cohort study utilizing data from the Veterans Affairs Surgical Quality Improvement Program (2000-2016).
  • Patients undergoing isolated CABG were categorized by LVEF (<25%, 25%-34%, ≥35%) and complication status (none, 1, or >1).
  • Multivariable Cox regression models were employed to assess the associations between LVEF, complications, and mortality risk.

Main Results:

  • A total of 61,477 patients were analyzed. Decreasing LVEF was significantly associated with increased odds of perioperative complications.
  • A dose-response relationship was observed between lower LVEF and increased long-term mortality risk.
  • Patients rescued from complications experienced decreased 10-year survival, irrespective of their LVEF; this association was particularly pronounced following multiple complications, where LVEF lost its predictive value for mortality.

Conclusions:

  • While reduced LVEF is linked to higher complication rates post-CABG, the long-term survival of patients rescued from complications is diminished, regardless of baseline LVEF.
  • Emphasis on complication prevention and prompt management is crucial for improving quality of care.
  • Further research is warranted to identify strategies for mitigating the long-term adverse survival impact of perioperative complications in CABG patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
228
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
339
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
282